BGLC - BioNexus Gene Lab Corp
2.67
0 0%
Share volume: 43,997
Last Updated: 05-09-2025
Healthcare/Services – Health:
-0.02%
PREVIOUS CLOSE
CHG
CHG%
$2.67
0.00
0.00%
Summary score
34%
Profitability
25%
Dept financing
23%
Liquidity
59%
Performance
40%
Sector
Services
Industry
Healthcare/Services – Health
Long-term ratios 30-Sep-2020 - 30-Sep-2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
2.72%
Return on assets
-1.14%
Return on sales
-7.82%
Return on invested capital
-22.94%
Total debt ratio
78.6%
Debt ratio change over timeo
-1.37%
Current Ratio
3.69%
Quick Ratio
3.02%
Cash Position Ratio
1.07%
Short-term ratios 30-Sep-2023 - 30-Sep-2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-1.29%
Return on sales
-7.43%
Return on invested capital
0%
Total debt ratio
170.06%
Debt ratio change over timeo
0%
Current Ratio
5.03%
Quick Ratio
4.27%
Cash Position Ratio
1.52%
Last quarter ratios 30-Sep-2024
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-7.93%
Return on sales
-50.85%
Return on invested capital
0%
Total debt ratio
175.2%
Debt ratio change over time
0%
Current Ratio
4.98%
Quick Ratio
3.99%
Cash Position Ratio
1.46%
Performance ratios (change over 4 years) 30-Sep-2020 - 30-Sep-2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-116.63%
Return on assets
-110.48%
Return on sales
-126.54%
Return on invested capital
24.3%
Total debt ratio
-137.25%
Debt ratio change over time
-1.37%
Current Ratio
-0.64%
Quick Ratio
-1.78%
Cash Position Ratio
-1.4%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | BGLC | HCA | LH | NTRA |
|---|---|---|---|---|
| Return on equity | 2.72% | -19.79% | 0% | -22.22% |
| Return on assets | -1.14% | 4.79% | 0% | -8.88% |
| Return on sales | -7.82% | 16.03% | 0% | -52.33% |
| Return on invested capital | -22.94% | 5.18% | 0% | 131.17% |
| Profitability | 25% | 51% | 0% | 25% |
| Total debt ratio | 78.6% | 103.23% | 0% | 50.99% |
| Debt ratio change over time | -1.37% | 20.1% | 0% | -0.5% |
| Dept financing | 19% | 50% | 0% | 12% |
| Current Ratio | 5.03% | 1.13% | 0% | 4.19% |
| Quick Ratio | 4.27% | 0.99% | 0% | 4.04% |
| Cash Position Ratio | 1.52% | 0.11% | 0% | 2.75% |
| Liquididy | 49% | 16% | 0% | 75% |
| Short-term ratios | BGLC | HCA | LH | NTRA |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | -10.2% |
| Return on assets | -1.29% | 4.67% | 0% | -4.07% |
| Return on sales | -7.43% | 15.42% | 0% | -16.74% |
| Return on invested capital | 0% | 0% | 0% | 62.87% |
| Profitability | 25% | 50% | 0% | 25% |
| Total debt ratio | 170.06% | 103.11% | 0% | 45.62% |
| Debt ratio change over time | 0% | 25.66% | 0% | -0.4% |
| Dept financing | 25% | 40% | 0% | 7% |
| Current Ratio | 5.03% | 1.13% | 0% | 4.19% |
| Quick Ratio | 4.27% | 0.99% | 0% | 4.04% |
| Cash Position Ratio | 1.52% | 0.11% | 0% | 2.75% |
| Liquididy | 64% | 12% | 0% | 69% |
